12 months on from winning startup of the year at the Bionow awards, LightOx’s
Senior Scientist, David Chisholm, has been awarded Promising Technologist of the Year.
Bionow awards are prestigious for the life science community in Northern England and their 18th year was no exception.
The North East was well represented at the event, with the Northern Alliance taking a table and also winning an award for Healthcare Project of the Year, along with familiar faces – Iksuda and BioSignatures
He has been involved with LightOx since the company’s inception and has been a key player in the design and development of LightOx’s photoactive compounds for the treatment of early-stage oral cancer.
David gained his PhD in Biological Chemistry in 2017 from Durham University, and stood out early on as a dynamic scientist capable of straddling multiple disciplines. David progressed to postdoctoral research in association with the University of Aberdeen and designed a series of novel compounds for the treatment of neurodegenerative diseases.
David now leads the chemistry team at LightOx, making a major contribution to the strategic aims of the company.
“We have greatly benefitted from having Dave in our company and he is truly exceptional in his professional manner and capabilities. He has led his projects to get results and been instrumental in the development of our latest drug candidates for Oral Cancer treatments. He is a true asset and a really nice guy!”
Sam Whitehouse, CEO, LightOx.